London Daily

Focus on the big picture.
Thursday, Oct 02, 2025

Hong Kong panel not ready to back Sinovac vaccine for city’s free jabs

Hong Kong panel not ready to back Sinovac vaccine for city’s free jabs

Advisory group’s chairman Professor Wallace Lau releases update after it discusses latest clinical data from manufacturer. Panel believes vaccine is safe but questions remain over when second dose is needed.

Hong Kong wants more information on the Covid-19 vaccines produced by Sinovac, before recommending the mainland China provider’s doses be used in the city’s free jabs programme.

Despite believing the vaccine to be safe, the city’s advisory panel still had questions after a three-hour discussion on Wednesday over new data provided by the Coronavac manufacturer.

Panel chairman Professor Wallace Lau Chak-sing said the group would meet again in two weeks’ time.

“After a long discussion, we believe the vaccine is safe and effective according to its data in the first and second stages,” Lau said.

Lau also said the panel had assessed phase-three clinical trials of the vaccines in Brazil, Turkey, and Indonesia and was satisfied with its effectiveness.

“The panel is of the view that the phase-three data presented showed the vaccine is effective. And in terms of safety of the vaccine, we feel that it is acceptable and the safety level is also high,” Lau said.

But he said the panel wanted answers on the difference in the results of injecting the second dose 14 days or 28 days after the first one, and whether antibodies would be created after the injection.

Lau said the panel hoped the manufacturer could provide data to answer these two questions in two weeks.

It was not immediately known if the panel’s decision would delay the city’s vaccination programme. But Lau said the group appreciated that the Lunar New Year holiday was approaching and it hoped to allow Sinovac reasonable time to provide additional information.

Lau would not say what might happen if that data was not provided in time.

Asked whether any delay would hamper the government’s vaccine scheme and affect the city’s pandemic control, Secretary for Food and Health Professor Sophia Chan Siu-chee said her bureau would have to wait for the panel to reach a definitive decision on the vaccine.

“The data provided is positive, and at the same time, they would like to see more data to make their final decision,” she said. “So, I think once we receive their recommendation, we, the Food and Health Bureau, will try our best to review and endorse the vaccines for emergency use.”

Respiratory medicine specialist Dr Leung Chi-chiu believed as long as Sinovac could provide the additional required data before the panel’s next meeting, it would not create too much uncertainty in the schedule for mass vaccination in Hong Kong.

“The question is what kinds of data they can provide, and whether the expert panel would be satisfied with what they are able to present,” he said.

Details about the difference in time between the first and second injections, and the antibodies created would be important for the decision, he said,especially when deciding on how long after the first jab people got the second dose, and whether that would be different for high-risk groups.

The panel previously asked Sinovac to provide relevant clinical data after it had been published in medical journals, but has now accepted phase-three data submitted to the World Health Organization because of time constraints cited by the manufacturer.

On Tuesday, Chief Executive Carrie Lam Cheng Yuet-ngor said her administration was following the city’s regulations, which allowed for approval of a vaccine without the final round of clinical data.

Asked if the panel felt pressured by Lam’s remarks, Lau said it made assessments based on science, an approach unanimously backed by all members.

“The decision that I have just announced has been arrived at by the whole panel, all 12 members agreed on the approach that I have just highlighted,” Lau said.

“I hope the public will not only consider whether the data has been published in a medical journal. I hope they have confidence in the 12 members of our expert panel,” he added. “We adopted the same way of reviewing a report to be published in a medical journal.”

Hong Kong expects its first batch of 1 million doses of the Pfizer-BioNTech vaccine by late February, and the government also bought a vaccine jointly developed by British-Swedish pharmaceutical firm AstraZeneca and the University of Oxford.

Last month, Lam revealed she had asked for the central government’s help in procuring a fourth vaccine.

Newsletter

Related Articles

0:00
0:00
Close
Trump Administration Launches “TrumpRx” Plan to Enable Direct Drug Sales at Deep Discounts
Trump Announces Intention to Impose 100 Percent Tariff on Foreign-Made Films
Altman Says GPT-5 Already Outpaces Him, Warns AI Could Automate 40% of Work
Singapore and Hong Kong Vie to Dominate Asia’s Rising Gold Trade
Trump Organization Teams with Saudi Developer on $1 Billion Trump Plaza in Jeddah
Manhattan Sees Surge in Office-to-Housing Conversions, Highest Since 2008
Switzerland and U.S. Issue Joint Assurance Against Currency Manipulation
Electronic Arts to Be Taken Private in Historic $55 Billion Buyout
Thomas Jacob Sanford Named as Suspect in Deadly Michigan Church Shooting and Arson
Russian Research Vessel 'Yantar' Tracked Mapping Europe’s Subsea Cables, Raising Security Alarms
New York Man Arrested After On-Air Confession to 2017 Parents’ Murders
U.S. Defense Chief Orders Sudden Summit of Hundreds of Generals and Admirals
Global Cruise Industry Posts Dramatic Comeback with 34.6 Million Passengers in 2024
Trump Claims FBI Planted 274 Agents at Capitol Riot, Citing Unverified Reports
India: Internet Suspended in Bareilly Amid Communal Clashes Between Muslims and Hindus
Supreme Court Extends Freeze on Nearly $5 Billion in U.S. Foreign Aid at Trump’s Request
Archaeologists Recover Statues and Temples from 2,000-Year-Old Sunken City off Alexandria
China Deploys 2,000 Workers to Spain to Build Major EV Battery Factory, Raising European Dependence
Speed Takes Over: How Drive-Through Coffee Chains Are Rewriting U.S. Coffee Culture
U.S. Demands Brussels Scrutinize Digital Rules to Prevent Bias Against American Tech
Ringo Starr Champions Enduring Beatles Legacy While Debuting Las Vegas Art Show
Private Equity’s Fundraising Surge Triggers Concern of European Market Shake-Out
Colombian President Petro Vows to Mobilize Volunteers for Gaza and Joins List of Fighters
FBI Removes Agents Who Kneeled at 2020 Protest, Citing Breach of Professional Conduct
Trump Alleges ‘Triple Sabotage’ at United Nations After Escalator and Teleprompter Failures
Shock in France: 5 Years in Prison for Former President Nicolas Sarkozy
Tokyo’s Jimbōchō Named World’s Coolest Neighbourhood for 2025
European Officials Fear Trump May Shift Blame for Ukraine War onto EU
BNP Paribas Abandons Ban on 'Controversial Weapons' Financing Amid Europe’s Defence Push
Typhoon Ragasa Leaves Trail of Destruction Across East Asia Before Making Landfall in China
The Personality Rights Challenge in India’s AI Era
Big Banks Rebuild in Hong Kong as Deal Volume Surges
Italy Considers Freezing Retirement Age at 67 to Avert Scheduled Hike
Italian City to Impose Tax on Visiting Dogs Starting in 2026
Arnault Denounces Proposed Wealth Tax as Threat to French Economy
Study Finds No Safe Level of Alcohol for Dementia Risk
Denmark Investigates Drone Incursion, Does Not Rule Out Russian Involvement
Lilly CEO Warns UK Is ‘Worst Country in Europe’ for Drug Prices, Pulls Back Investment
Nigel Farage Emerges as Central Force in British Politics with Reform UK Surge
Disney Reinstates ‘Jimmy Kimmel Live!’ after Six-Day Suspension over Charlie Kirk Comments
U.S. Prosecutors Move to Break Up Google’s Advertising Monopoly
Nvidia Pledges Up to $100 Billion Investment in OpenAI to Power Massive AI Data Center Build-Out
U.S. Signals ‘Large and Forceful’ Support for Argentina Amid Market Turmoil
Nvidia and Abu Dhabi’s TII Launch First AI-&-Robotics Lab in the Middle East
Vietnam Faces Up to $25 Billion Export Loss as U.S. Tariffs Bite
Europe Signals Stronger Support for Taiwan at Major Taipei Defence Show
Indonesia Court Upholds Military Law Amid Concerns Over Expanded Civilian Role
Larry Ellison, Michael Dell and Rupert Murdoch Join Trump-Backed Bid to Take Over TikTok
Trump and Musk Reunite Publicly for First Time Since Fallout at Kirk Memorial
Vietnam Closes 86 Million Untouched Bank Accounts Over Biometric ID Rules
×